Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arun Upadhyay Insider Profile
11 Followers
Arun Upadhyay, Chief Scientific Officer, Head of Research, Development and Medical at Ocugen, holds 347.83K shares in Ocugen (Ticker: OCGN).
Arun Upadhyay Ocugen (OCGN)Chief Scientific Officer, Head of Research, Development and Medical
Ocugen (OCGN)
Chief Scientific Officer, Head of Research, Development and Medical
Not Ranked
Arun Upadhyay has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Scientific Officer, Head of Research, Development and Medical
Roles that Arun Upadhyay holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Arun Upadhyay
Arun Upadhyay's Trading History
List of latest transactions for each holding click on a transaction to see Arun Upadhyay's performance on stock
You May Also Like
Arun Upadhyay insider profile FAQ
What is the percentage of profitable transactions made by Arun Upadhyay?
The percentage of profitable transactions made by Arun Upadhyay is ―.
What is the average return per transaction made by Arun Upadhyay?
The average return per transaction made by Arun Upadhyay is ―.
What stocks does Arun Upadhyay hold?
Arun Upadhyay holds: OCGN stocks.
What was Arun Upadhyay’s latest transaction?
Arun Upadhyay latest transaction was an Uninformative Sell of $985.14.
What was Arun Upadhyay's most profitable transaction?
Arun Upadhyay’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Arun Upadhyay's role in Ocugen?
Arun Upadhyay's role in Ocugen is Chief Scientific Officer, Head of Research, Development and Medical.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.